Explore the Program
The Symposiums at ACC.24 offer consecutive sessions which provide attendees with the opportunity to focus on a specific area of interest. All members of the cardiovascular care team will benefit from these immersive programs.
Cardiovascular Update For the Clinician: A Symposium by Valentin Fuster
Led by Valentin Fuster, MD, PhD, MACC, Cardiovascular Update For the Clinician will feature expert presentations and panel discussions in each topic area. Immerse yourself in the latest advances in the treatment of cardiovascular disease and learn how to integrate it into your daily practice. Expand your knowledge and expertise with comprehensive updates in patient care.
This year's symposium is focused on four topic areas: coronary artery disease (CAD), myocardial disease and heart failure (HF), electrical failure and rhythm disorders, and valvular heart disease (VHD). In CAD, delve into the imagonomics of silent atherogenesis, employing CT angiography for precise identification, explore evolving strategies for managing antithrombotics in coronary syndromes, and uncover the evolution in the management of stable coronary multivessel disease, comparing CABG, PCI, and optimal medical therapy. In myocardial disease and HF, explore the evolution of imaging approaches and clinical genetics for seven myocardial diseases, and learn about recent advances in acute and chronic assist devices. The topic of electrical failure introduces the challenges faced in atrial fibrillation, emphasizing quality of life and stroke prevention, along with cutting-edge tools for ablation and LAA closure. Lastly, in VHD, experts will tackle diagnostic and management challenges in aortic and mitral valve disorders, hypertrophic cardiomyopathy, and the dilated thoracic and abdominal aorta, exploring innovative strategies aligned with new guidelines.
For busy clinicians and general cardiologists who seek a comprehensive update of new advances in cardiovascular care and how to integrate them into their practices — this is program to attend.
- Coronary Artery Disease – Challenges in 2024: Atherogenesis and Coronary Syndromes (Session 101)
- Myocardial Disease and Heart Failure – Challenges in 2024: Imagenomics, Pharmacology, Devices (Session 103)
- Electrical Failure – 2024: Rhythm Disorders (Session 106)
- Valvular Heart Disease, IHSS and Aorta – 2024: Understanding and Management (Session 107)
With the complexity of when and how to use various medications, PharmDs play an important role as members of cardiovascular care team in this era of increasingly coordinated care. The Pharmacology Program will cover hot topics in cardiovascular medicine that are key issues that pharmacists, as well as other health care team members, face in managing complex patients.
The first session will focus on hot topics in cardio-oncology and the growing list of new agents causing cardiotoxicity, best practices for managing hypertension in oncology patients treated with TKI/VEGF inhibitors, and frequent drug interactions with oncology treatments.
The second session will dive into practical management of atrial fibrillation (AF) and explore nuanced thromboembolism risk stratification, considerations beyond CHA2DS2-VASC, anticoagulation for device-detected AF, and tailored approaches for special populations.
The last session in the series will review the latest agents for the management of diuretic resistance, strategies for lipid management, antithrombotic regimens in acute coronary syndrome (ACS), and highlight anticoagulation pearls in patients with mechanical circulatory support devices Join us for an information-packed journey with these dynamic sessions, shaping the future of cardiovascular medicine.